T1	Participants 62 112	patients undergoing surgery for colorectal cancer.
T2	Participants 265 314	patients undergoing surgery for colorectal cancer
T3	Participants 402 484	Patients were randomly allocated to control (n = 13) or treatment groups (n = 12).
